Literature DB >> 17916779

Targeted deletion of thioredoxin-interacting protein regulates cardiac dysfunction in response to pressure overload.

Jun Yoshioka1, Kenichi Imahashi, Scott A Gabel, William A Chutkow, Aurora A Burds, Joseph Gannon, P Christian Schulze, Catherine MacGillivray, Robert E London, Elizabeth Murphy, Richard T Lee.   

Abstract

Biomechanical overload induces cardiac hypertrophy and heart failure, and reactive oxygen species (ROS) play a role in both processes. Thioredoxin-Interacting Protein (Txnip) is encoded by a mechanically-regulated gene that controls cell growth and apoptosis in part through interaction with the endogenous dithiol antioxidant thioredoxin. Here we show that Txnip is a critical regulator of the cardiac response to pressure overload. We generated inducible cardiomyocyte-specific and systemic Txnip-null mice (Txnip-KO) using Flp/frt and Cre/loxP technologies. Compared with littermate controls, Txnip-KO hearts had attenuated cardiac hypertrophy and preserved left ventricular (LV) contractile reserve through 4 weeks of pressure overload; however, the beneficial effects were not sustained and Txnip deletion ultimately led to maladaptive LV remodeling at 8 weeks of pressure overload. Interestingly, these effects of Txnip deletion on cardiac performance were not accompanied by global changes in thioredoxin activity or ROS; instead, Txnip-KO hearts had a robust increase in myocardial glucose uptake. Thus, deletion of Txnip plays an unanticipated role in myocardial energy homeostasis rather than redox regulation. These results support the emerging concept that the function of Txnip is not as a simple thioredoxin inhibitor but as a metabolic control protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17916779     DOI: 10.1161/CIRCRESAHA.106.160515

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  49 in total

1.  Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity.

Authors:  Jie Yan; Martin E Young; Lei Cui; Gary D Lopaschuk; Ronglih Liao; Rong Tian
Journal:  Circulation       Date:  2009-05-18       Impact factor: 29.690

2.  Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins.

Authors:  Parth Patwari; William A Chutkow; Kiersten Cummings; Valerie L R M Verstraeten; Jan Lammerding; Eric R Schreiter; Richard T Lee
Journal:  J Biol Chem       Date:  2009-07-15       Impact factor: 5.157

3.  Resveratrol Decreases TXNIP mRNA and Protein Nuclear Expressions With an Arterial Function Improvement in Old Mice.

Authors:  Tatiana Bedarida; Stephanie Baron; Françoise Vibert; Audrey Ayer; Daniel Henrion; Elizabeth Thioulouse; Carmen Marchiol; Jean-Louis Beaudeux; Charles-Henry Cottart; Valerie Nivet-Antoine
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-06-03       Impact factor: 6.053

4.  Thioredoxin regulates adipogenesis through thioredoxin-interacting protein (Txnip) protein stability.

Authors:  William A Chutkow; Richard T Lee
Journal:  J Biol Chem       Date:  2011-06-24       Impact factor: 5.157

5.  Time-Saving Benefits of Intravital Staining.

Authors:  Catherine Macgillivray; Jeremy Sylvan; Richard T Lee; Hayden Huang
Journal:  J Histotechnol       Date:  2008-09       Impact factor: 0.714

6.  TXNIP in Agrp neurons regulates adiposity, energy expenditure, and central leptin sensitivity.

Authors:  Clemence Blouet; Shun-Mei Liu; Young-Hwan Jo; Streamson Chua; Gary J Schwartz
Journal:  J Neurosci       Date:  2012-07-18       Impact factor: 6.167

7.  Mechanisms for the adverse effects of late gestational increases in maternal cortisol on the heart revealed by transcriptomic analyses of the fetal septum.

Authors:  Elaine M Richards; Charles E Wood; Maria Belen Rabaglino; Andrew Antolic; Maureen Keller-Wood
Journal:  Physiol Genomics       Date:  2014-05-27       Impact factor: 3.107

8.  TXNIP regulates myocardial fatty acid oxidation via miR-33a signaling.

Authors:  Junqin Chen; Martin E Young; John C Chatham; David K Crossman; Louis J Dell'Italia; Anath Shalev
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-03       Impact factor: 4.733

9.  Dual targeting of the antagonistic pathways mediated by Sirt1 and TXNIP as a putative approach to enhance the efficacy of anti-aging interventions.

Authors:  Shaker A Mousa; Christine Gallati; Tessa Simone; Emmy Dier; Murat Yalcin; Evgeny Dyskin; Sudha Thangirala; Christine Hanko; Abdelhadi Rebbaa
Journal:  Aging (Albany NY)       Date:  2009-03-31       Impact factor: 5.682

10.  Deletion of the alpha-arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity.

Authors:  William A Chutkow; Andreas L Birkenfeld; Jonathan D Brown; Hui-Young Lee; David W Frederick; Jun Yoshioka; Parth Patwari; Romy Kursawe; Samuel W Cushman; Jorge Plutzky; Gerald I Shulman; Varman T Samuel; Richard T Lee
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.